BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 22224265)

  • 1. Antidiabetic activity of Terminalia sericea constituents.
    Nkobole N; Houghton PJ; Hussein A; Lall N
    Nat Prod Commun; 2011 Nov; 6(11):1585-8. PubMed ID: 22224265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. alpha-Glucosidase and alpha-amylase inhibitory activities of saponins from traditional Chinese medicines in the treatment of diabetes mellitus.
    Dou F; Xi M; Wang J; Tian X; Hong L; Tang H; Wen A
    Pharmazie; 2013 Apr; 68(4):300-4. PubMed ID: 23700798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polyphenol-rich extract and fractions of Terminalia phaeocarpa Eichler possess hypoglycemic effect, reduce the release of cytokines, and inhibit lipase, α-glucosidase, and α-amilase enzymes.
    Gomes JHS; Mbiakop UC; Oliveira RL; Stehmann JR; Pádua RM; Cortes SF; Braga FC
    J Ethnopharmacol; 2021 May; 271():113847. PubMed ID: 33515684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitory activity of α-amylase and α-glucosidase by plant extracts from the Brazilian cerrado.
    Souza PM; Sales PM; Simeoni LA; Silva EC; Silveira D; Magalhães Pde O
    Planta Med; 2012 Mar; 78(4):393-9. PubMed ID: 22134849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Ficus racemosa stem bark on the activities of carbohydrate hydrolyzing enzymes: an in vitro study.
    Ahmed F; Urooj A
    Pharm Biol; 2010 May; 48(5):518-23. PubMed ID: 20645793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. alpha-Glucosidase inhibitory constituents from stem bark of Terminalia superba (Combretaceae).
    Wansi JD; Lallemand MC; Chiozem DD; Toze FA; Mbaze LM; Naharkhan S; Iqbal MC; Tillequin F; Wandji J; Fomum ZT
    Phytochemistry; 2007 Aug; 68(15):2096-100. PubMed ID: 17434189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibacterial activities and cytotoxicity of terpenoids isolated from Spirostachys africana.
    Mathabe MC; Hussein AA; Nikolova RV; Basson AE; Meyer JJ; Lall N
    J Ethnopharmacol; 2008 Feb; 116(1):194-7. PubMed ID: 18191928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-diabetic and anti-hypertensive potential of sprouted and solid-state bioprocessed soybean.
    McCue P; Kwon YI; Shetty K
    Asia Pac J Clin Nutr; 2005; 14(2):145-52. PubMed ID: 15927931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Triterpene acids isolated from Lagerstroemia speciosa leaves as alpha-glucosidase inhibitors.
    Hou W; Li Y; Zhang Q; Wei X; Peng A; Chen L; Wei Y
    Phytother Res; 2009 May; 23(5):614-8. PubMed ID: 19107840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro alpha-glucosidase and alpha-amylase enzyme inhibitory effects of Andrographis paniculata extract and andrographolide.
    Subramanian R; Asmawi MZ; Sadikun A
    Acta Biochim Pol; 2008; 55(2):391-8. PubMed ID: 18511986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. α-Glucosidase- and α-amylase-inhibitory activities of phlorotannins from Eisenia bicyclis.
    Eom SH; Lee SH; Yoon NY; Jung WK; Jeon YJ; Kim SK; Lee MS; Kim YM
    J Sci Food Agric; 2012 Aug; 92(10):2084-90. PubMed ID: 22271637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soybean phenolic-rich extracts inhibit key-enzymes linked to type 2 diabetes (α-amylase and α-glucosidase) and hypertension (angiotensin I converting enzyme) in vitro.
    Ademiluyi AO; Oboh G
    Exp Toxicol Pathol; 2013 Mar; 65(3):305-9. PubMed ID: 22005499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antioxidant and anti-glycation capacities of some medicinal plants and their potential inhibitory against digestive enzymes related to type 2 diabetes mellitus.
    Franco RR; da Silva Carvalho D; de Moura FBR; Justino AB; Silva HCG; Peixoto LG; Espindola FS
    J Ethnopharmacol; 2018 Apr; 215():140-146. PubMed ID: 29274842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypoglycaemic activity of four plant extracts traditionally used in South Africa for diabetes.
    Deutschländer MS; van de Venter M; Roux S; Louw J; Lall N
    J Ethnopharmacol; 2009 Jul; 124(3):619-24. PubMed ID: 19422900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New polyhydroxytriterpenoid derivatives from fruits of Terminalia chebula Retz. and their α-glucosidase and α-amylase inhibitory activity.
    Lee DY; Yang H; Kim HW; Sung SH
    Bioorg Med Chem Lett; 2017 Jan; 27(1):34-39. PubMed ID: 27890380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitory effects of medicinal mushrooms on α-amylase and α-glucosidase - enzymes related to hyperglycemia.
    Su CH; Lai MN; Ng LT
    Food Funct; 2013 Apr; 4(4):644-9. PubMed ID: 23396484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of alpha-glucosidase by aqueous extracts of some potent antidiabetic medicinal herbs.
    Onal S; Timur S; Okutucu B; Zihnioğlu F
    Prep Biochem Biotechnol; 2005; 35(1):29-36. PubMed ID: 15704495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anolignan B: a bioactive compound from the roots of Terminalia sericea.
    Eldeen IM; Elgorashi EE; Mulholland DA; van Staden J
    J Ethnopharmacol; 2006 Jan; 103(1):135-8. PubMed ID: 16257162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypoglycaemic and amylase inhibitory activities of leaves of Spondias mombin Linn.
    Fred-Jaiyesimi AA; Wilkins MR; Abo KA
    Afr J Med Med Sci; 2009 Dec; 38(4):343-9. PubMed ID: 20499628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antioxidative activity and inhibition of key enzymes linked to type-2 diabetes (α-glucosidase and α-amylase) by Khaya senegalensis.
    Ibrahim MA; Koorbanally NA; Islam MS
    Acta Pharm; 2014 Sep; 64(3):311-24. PubMed ID: 25296677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.